LATEST NEWS

June 20, 2023

We have updated the Diabeter Research website with a number of publications of studies in which Diabeter authors were involved:

April 12, 2023

UPDATE PSYCHOLOGY PUBLICATIONS 2022-2023

We have updated the Diabeter Research website with a number of publications of studies in which Diabeter psychologist Giesje Nefs was involved:

March 7, 2023

SECOND PUBLICATION OF JDRF-PROJECT ‘BIOMARKERS OF HETEROGENEITY IN TYPE 1 DIABETES’

C-peptide and long-standing T1D

July 4, 2022

UPDATE PUBLICATIONS FIRST HALF OF 2022

We have updated the Diabeter Research website with a number of publications of studies in which Diabeter, or employees of Diabeter, were involved

January 25, 2022

UPDATE PUBLICATIONS 2021/2022

We have updated the Diabeter Research website with a number of publications of studies in which Diabeter, or employees of Diabeter, were involved

November 17, 2021

CONSENSUS STATEMENT DO-IT-YOURSELF AUTOMATED INSULIN DELIVERY SYSTEMS

Recently a consensus statement on the use of open-source insulin delivery (AID) systems was published. Diabeter pediatrician Per Winterdijk, himself an open-source AID system user, contributed to the statement

November 10, 2021

LIFE EXPECTANCY, MORTALITY, PREVENTION OF COMPLICATIONS AND HOPE

Disturbing statistics on diabetes were presented in the Dutch press in October 2021

October 4, 2021

FIRST PUBLICATION OF JDRF-PROJECT ‘BIOMARKERS OF HETEROGENEITY IN TYPE 1 DIABETES’

C-peptide and impaired awareness of glycemia

June 1, 2021

PROGRESS TOWARDS PREVENTION OF TYPE 1 DIABETES: TEPLIZUMAB

Approval of Teplizumab for further application and development

February 15, 2021

“NEW CLOSED-LOOP INSULIN SYSTEMS”: REVIEW OF RECENT CLOSED-LOOP SYSTEMS

February 2, 2021

DIAMYD MEDICAL META-ANALYSIS UPDATED WITH RESULTS FROM DIAGNODE-2 TRIAL

September 17, 2020

DIAMYD MEDICAL PRESENTS RESULTS FROM DIAGNODE 2 TRIAL

September 7, 2020

DIAMYD®: ANOTHER STEP TOWARDS INDIVIDUALIZED THERAPY FOR TYPE 1 DIABETES

July 20, 2020

DIAGNODE-2: RESULTS FROM TRIAL WITH DIABETES VACCINE DIAMYD® (GAD65-ALUM) EXPECTED SEPTEMBER 2020

April 20, 2020

TYPE 1 DIABETES CARE IN COVID-19 TIMES: THE DIABETER EXPERIENCE

February 21, 2020

NEWS FROM ATTD 2020

February 4, 2020

PROF. EELCO DE KONING’S RESEARCH GROUP HAS BEEN GRANTED 1.2 MILLION EUROS FOR TWO HORIZON 2020-PROJECTS ON STEM CELL PRODUCTS

January 30, 2020

DIABETER INTERNSHIP ON THE ROLE OF PRECONCEPTION GLYCEMIC VARIABILITY IN PREGNANCY/DELIVERY IN WOMEN WITH T1D

December 18, 2019

PHASE I/II TRIAL REGENERATE-1 WITH GABA FORMULATION HAS STARTED

Recently published press release from Diamyd

December 17, 2019

A NEW WAY OF LOOKING AT HETEROGENEITY IN TYPE 1 DIABETES: THE ENDOTYPE

Recently published in Diabetes Care

December 3, 2019

SCREENING FOR TYPE 1 DIABETES?

Update from ISPAD 2019